The Global Clinical Data Analytics Market was valued at USD 3.974 billion in 2018 and is expected to register a CAGR of 33.07% over the forecast period (2019-2024). Clinical data analytics in the healthcare sector plays a prominent role in curing and predicting diseases, which increases the quality of care and nullifies preventable deaths, which occur due to the negligence of some chronic diseases.
Availability of new technology and software, such as the internet of things (IoT) and mHealth, has provided the patients with ease of access to a range of services. With the aid of these solutions, patients can track their health data and share it with their respective healthcare professionals for any further treatment.
The increasing number of healthcare groups are currently looking toward analytics solutions for effective population health management, which is expected to increase the demand for clinical data analytics over the forecast period.
Increasing security breaches and data theft, coupled with low internet penetration in developing countries, are expected to restrain the market over the forecast period.
Scope of the Report
Clinical data analytics help physicians take care of a patientŐs health conditions better, as well as aid in understanding the health status of the patients concerned. The technology can vary according to the data involved or the users of the information or the actions, which are at the discretion of decision makers, such as nurses, doctors, public health officials, senior management, etc.
Key Market Trends
Quality Improvement and Clinical Bench-marking to Hold Significant Share
Healthcare professionals have always had a great deal of information they could use, but that data was not easy to access manually due to the huge sheer volume of the data. With the advent of digitization, the ability to deconstruct data in medical imaging for analyzing can cause a drastic change in the healthcare industry.
Combining huge volumes and types of data along with the technological improvements for analyzing massive amounts of information is creating significant opportunities for improving healthcare quality across the globe.
Leveraging technologies like big data and utilizing computer systems such as IBM Watson allows analysis of verbal expressions, degradation in handwriting, facial expressions in predicting the disease among a host of other functions.
United States to be a Major Market
As per the National Institutes of Health, in 2016, the United States alone accounted for 40% of clinical trials worldwide. The collected data that is being generated from different sources need to be studied and analyzed for chalking out strategies for effective population health management. Under the new rules by the US government for Medicare, hospitals and doctors will be subject to financial penalties under Medicare if they are not using electronic health records (EHR). Though the United States has always been known to be a pioneer in use of advanced technologies for treating patients, doctors and hospitals have been slow to replace paper records with electronic records. These steps are being taken to put these EHRŐs to meaningful use. Enforcement of these new regulations is expected to provide impetus to the demand for clinical data analytics solutions in the region.
The clinical data analytics market has been gaining a competitive edge in recent years In terms of market share, few of the major players currently dominate the market. These major players with a prominent share in the market are focusing on expanding their customer base across foreign countries. These companies are leveraging on strategic collaborative initiatives to increase their market share and increase their profitability. In May 2017, Truman Medical Centers (TMC) in Missouri has collaborated with Cerner to develop a new set of population health analytics algorithms to support a comprehensive chronic care management program for patients.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Value Chain Analysis
4.3 Industry Attractiveness Porter's Five Force Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
4.4 Introduction to Market Drivers and Restraints
4.5 Market Drivers
4.5.1 Increasing Focus On Population Health Management
4.5.2 Government Healthcare Policies Expected To Propel The Market Growth
4.5.3 Clinical Data Analytics Enabling Personalized Patient Care
4.5.4 Growing Need To Contain Healthcare Expenditure
4.6 Market Restraints
4.6.1 Lack of Infrastructural Facilities In Various Government And Private Hospitals
4.6.2 Low Internet Penetration In The Emerging Economies
4.7 Market Opportunities
4.7.1 Increasing Adoption of Electronic Data Recording System
4.8 Market Challenges
4.8.1 Maintaining The Integrity And Privacy Of The Collected Data
5 MARKET SEGMENTATION
5.1 By Deployment Model
5.2 By Application
5.2.1 Quality Improvement and Clinical Benchmarking
5.2.2 Clinical Decision Support
5.2.3 Regulatory Reporting and Compliance
5.2.4 Comparative Analytics/Comparative Effectiveness
5.2.5 Precision Health
5.3 By End User
5.4.1 North America
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.4.4 South America
126.96.36.199 Rest of South America
5.4.5 Middle East and Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations And Partnerships
6.3 New Product Launches
6.4 Company Profiles
6.4.1 Allscripts Healthcare Solutions Inc.
6.4.3 CareEvolution, Inc.
6.4.4 Cerner Corp
6.4.5 Health Catalyst
6.4.6 IBM Corporation
6.4.7 Koninklijke Philips N.V
6.4.8 McKesson Corporation
6.4.9 Optum Inc.
6.4.10 Oracle Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.